Author | Bushra Mushtaq, FRCS


Real-world experience: Positive DME treatment outcomes observed with FAc implant at UK centre

Dr Mushtaq discusses one centre’s initial post-marketing experience with the fluocinolone acetonide intravitreal implant 0.19 mg. The implant demonstrated favourable outcomes and good patient acceptance.

New content coming soon, please check back later.